{"transactions":[{"id":1861741,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T22:06:53.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on the earlier of June 6, 2024 or the day prior to the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":17500,"derivative":{"exercise_price":9.01,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-23-035560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000120919123035560/doc4.xml","form_type":"4"}},{"id":2243667,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T21:00:43.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on the earlier of June 1, 2023 or the day prior to the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":17500,"derivative":{"exercise_price":2.09,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-22-034171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000120919122034171/doc4.xml","form_type":"4"}},{"id":2751067,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-12T19:14:24.000Z","date":"2021-04-08","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on April 8, 2022."}],"balance_after":14000,"derivative":{"exercise_price":15,"expiration_date":"2031-04-07","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-21-026338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000120919121026338/doc4.xml","form_type":"4"}},{"id":3006784,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:23.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":15398,"price":17.39,"value":267771.22,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":17.11,"underlying":"Common Stock","underlying_shares":15398},"source":{"system":"sec-edgar","filing":"0000899243-20-028177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/doc4.xml","form_type":"4"}},{"id":3006783,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:23.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":11432,"price":14.6,"value":166907.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":19.9,"underlying":"Common Stock","underlying_shares":11432},"source":{"system":"sec-edgar","filing":"0000899243-20-028177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/doc4.xml","form_type":"4"}},{"id":3006782,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:23.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":7500,"price":1.71,"value":12825.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":32.79,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-20-028177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/doc4.xml","form_type":"4"}},{"id":3006781,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:23.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":17500,"price":16.24,"value":284200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":18.26,"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000899243-20-028177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/doc4.xml","form_type":"4"}},{"id":3006780,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:23.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":19755,"price":19.1,"value":377320.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":15.4,"underlying":"Common Stock","underlying_shares":19755},"source":{"system":"sec-edgar","filing":"0000899243-20-028177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/doc4.xml","form_type":"4"}},{"id":3006779,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:23.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":52421,"price":28.21,"value":1478796.41,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":6.29,"underlying":"Common Stock","underlying_shares":52421},"source":{"system":"sec-edgar","filing":"0000899243-20-028177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/doc4.xml","form_type":"4"}},{"id":3006778,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-10-14T16:15:23.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":7840,"price":34.5,"value":270480.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of to SPN MergerSub, Inc. (\"Merger Sub\"), which, pursuant to the Agreement and Plan of Merger, dated August 29, 2020, by and between the Issuer, Societes des Produits Nestle S.A., (\"Nestle\"), and Merger Sub (the \"Merger Agreement\"), commenced a tender offer to acquire any and all of the outstanding shares of the Issuer's common stock (other than those shares owned by Nestle and its affiliates) at a purchase price of $34.50 per share (the \"Offer Price\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Merger Agreement, each Issuer restricted stock unit (\"RSU\") that was outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") vested in full, terminated, and was converted into the right to receive a cash payment equal to (i) the Offer Price multiplied by (ii) the number of shares of common stock subject to the RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-028177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/doc4.xml","form_type":"4"}},{"id":3006777,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-10-14T16:15:23.000Z","date":"2020-10-10","kind":"other","acquired":false,"shares":10221,"price":34.5,"value":352624.5,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-028177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/doc4.xml","form_type":"4"}},{"id":3130103,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option\n(right to buy)","published_at":"2020-05-29T19:12:01.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":15398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":15398,"derivative":{"exercise_price":17.11,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":15398},"source":{"system":"sec-edgar","filing":"0000899243-20-014609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320014609/doc4.xml","form_type":"4"}},{"id":3130102,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-05-29T19:12:01.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":7840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") and will be settled in common stock upon vesting.  The RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":18061,"source":{"system":"sec-edgar","filing":"0000899243-20-014609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320014609/doc4.xml","form_type":"4"}},{"id":3509909,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-28T21:19:07.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":11432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":11432,"derivative":{"exercise_price":19.9,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":11432},"source":{"system":"sec-edgar","filing":"0000899243-19-014965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924319014965/doc4.xml","form_type":"4"}},{"id":3509908,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-05-28T21:19:07.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":6442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") and will be settled in common stock upon vesting.  The RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":10221,"source":{"system":"sec-edgar","filing":"0000899243-19-014965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924319014965/doc4.xml","form_type":"4"}},{"id":3918199,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-24T17:09:11.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":32.79,"expiration_date":"2028-05-23","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-18-013931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924318013931/doc4.xml","form_type":"4"}},{"id":3918198,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-05-24T17:09:11.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") and will be settled in common stock upon vesting.  The RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":3779,"source":{"system":"sec-edgar","filing":"0000899243-18-013931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924318013931/doc4.xml","form_type":"4"}},{"id":4137610,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-08T16:31:21.000Z","date":"2017-12-06","kind":"other","acquired":true,"shares":29,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 6, 2017, Aisling Capital III, LP and certain of its affiliated funds distributed a portion of the shares of common stock of the Issuer (the \"Common Stock\") beneficially owned by such funds to their partners for no consideration. In connection with the distributions, the reporting person received 29 shares of Common Stock. In accordance with Rule 16a-9, such acquisition is exempt from Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":29,"source":{"system":"sec-edgar","filing":"0000950142-17-002181","document":"es1701213_4-seltzer.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000095014217002181/es1701213_4-seltzer.xml","form_type":"4"}},{"id":4300922,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":112552,"kind":"person","name":"Seltzer Stacey Denenberg","position":1,"cik":"0001648895","reported_name":"Seltzer Stacey Denenberg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-30T16:06:02.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2018 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":18.26,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000899243-17-014692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924317014692/doc4.xml","form_type":"4"}}]}